Frontiers in Pharmacology, 2022 · DOI: 10.3389/fphar.2022.860757 · Published: July 8, 2022
Spinal cord injury (SCI) often leads to motor and sensory dysfunction of the lower limbs. Rehmannia glutinosa, a traditional Chinese medicine, is used in neurodegenerative diseases. Catalpol (CAT), an extract of Rehmannia glutinosa, has antioxidant, antiapoptotic, and neuroprotective effects and can treat SCI by inhibiting ER stress-mediated neuronal apoptosis.
Catalpol could be developed as a therapeutic agent for spinal cord injury.
Treatments aimed at reducing endoplasmic reticulum stress may improve outcomes after SCI.
This study supports the use of Rehmannia glutinosa, a traditional Chinese medicine, in treating neurodegenerative conditions and SCI.